803 related articles for article (PubMed ID: 12768634)
1. Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma.
Veeramachaneni R; Nordberg ML; Shi R; Herrera GA; Turbat-Herrera EA
Diagn Cytopathol; 2003 Jun; 28(6):301-7. PubMed ID: 12768634
[TBL] [Abstract][Full Text] [Related]
2. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology.
Skacel M; Fahmy M; Brainard JA; Pettay JD; Biscotti CV; Liou LS; Procop GW; Jones JS; Ulchaker J; Zippe CD; Tubbs RR
J Urol; 2003 Jun; 169(6):2101-5. PubMed ID: 12771727
[TBL] [Abstract][Full Text] [Related]
3. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
[TBL] [Abstract][Full Text] [Related]
4. Intermediate-risk urothelial carcinoma: an unresolved problem?
Pycha A; Lodde M; Comploj E; Negri G; Egarter-Vigl E; Vittadello F; Lusuardi L; Palermo S; Mian C
Urology; 2004 Mar; 63(3):472-5. PubMed ID: 15028440
[TBL] [Abstract][Full Text] [Related]
5. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma.
Halling KC; King W; Sokolova IA; Meyer RG; Burkhardt HM; Halling AC; Cheville JC; Sebo TJ; Ramakumar S; Stewart CS; Pankratz S; O'Kane DJ; Seelig SA; Lieber MM; Jenkins RB
J Urol; 2000 Nov; 164(5):1768-75. PubMed ID: 11025767
[TBL] [Abstract][Full Text] [Related]
6. [Numerical aberrations of chromosomes 11 and 17 detected by fish--fluorescence in situ hybridization combined with cytology in exfoliated cells from voided urine in patients with urothelial carcinoma of the bladder].
Asali MG; Kaneti J; Manor E
Harefuah; 2007 Dec; 146(12):914-9, 1000. PubMed ID: 18254439
[TBL] [Abstract][Full Text] [Related]
7. Combined analysis of morphology and fluorescence in situ hybridization significantly increases accuracy of bladder cancer detection in voided urine samples.
Daniely M; Rona R; Kaplan T; Olsfanger S; Elboim L; Zilberstien Y; Friberger A; Kidron D; Kaplan E; Lew S; Leibovitch I
Urology; 2005 Dec; 66(6):1354-9. PubMed ID: 16360483
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence in situ hybridization for detecting transitional cell carcinoma: implications for clinical practice.
Laudadio J; Keane TE; Reeves HM; Savage SJ; Hoda RS; Lage JM; Wolff DJ
BJU Int; 2005 Dec; 96(9):1280-5. PubMed ID: 16287445
[TBL] [Abstract][Full Text] [Related]
9. Quantitative molecular urinary cytology by fluorescence in situ hybridization: a tool for tailoring surveillance of patients with superficial bladder cancer?
Bollmann M; Heller H; Bánkfalvi A; Griefingholt H; Bollmann R
BJU Int; 2005 Jun; 95(9):1219-25. PubMed ID: 15892805
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence in situ hybridization assay detects upper urinary tract transitional cell carcinoma in patients with asymptomatic hematuria and negative urine cytology.
Huang WT; Li LY; Pang J; Ruan XX; Sun QP; Yang WJ; Gao X
Neoplasma; 2012; 59(4):355-60. PubMed ID: 22489689
[TBL] [Abstract][Full Text] [Related]
11. UroVysion® multiprobe FISH in the triage of equivocal urinary cytology cases.
Bubendorf L; Piaton E
Ann Pathol; 2012 Dec; 32(6):e52-6, 438-43. PubMed ID: 23244486
[TBL] [Abstract][Full Text] [Related]
12. DNA image cytometry and fluorescence in situ hybridization for noninvasive detection of urothelial tumors in voided urine.
Dalquen P; Kleiber B; Grilli B; Herzog M; Bubendorf L; Oberholzer M
Cancer; 2002 Dec; 96(6):374-9. PubMed ID: 12478686
[TBL] [Abstract][Full Text] [Related]
13. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
May M; Hakenberg OW; Gunia S; Pohling P; Helke C; Lübbe L; Nowack R; Siegsmund M; Hoschke B
Urology; 2007 Sep; 70(3):449-53. PubMed ID: 17688921
[TBL] [Abstract][Full Text] [Related]
14. Fluorescence in situ hybridization for detecting upper urinary tract tumors--a preliminary report.
Akkad T; Brunner A; Pallwein L; Gozzi C; Bartsch G; Mikuz G; Steiner H; Verdorfer I
Urology; 2007 Oct; 70(4):753-7. PubMed ID: 17991550
[TBL] [Abstract][Full Text] [Related]
15. UroVysion compared with cytology and quantitative cytology in the surveillance of non-muscle-invasive bladder cancer.
Moonen PM; Merkx GF; Peelen P; Karthaus HF; Smeets DF; Witjes JA
Eur Urol; 2007 May; 51(5):1275-80; discussion 1280. PubMed ID: 17084511
[TBL] [Abstract][Full Text] [Related]
16. Surveillance of patients with bladder carcinoma using fluorescent in-situ hybridization on bladder washings.
Bergman J; Reznichek RC; Rajfer J
BJU Int; 2008 Jan; 101(1):26-9. PubMed ID: 17850364
[TBL] [Abstract][Full Text] [Related]
17. Utility of a multiprobe fluorescence in situ hybridization assay in the detection of superficial urothelial bladder cancer.
Marín-Aguilera M; Mengual L; Ribal MJ; Burset M; Arce Y; Ars E; Oliver A; Villavicencio H; Algaba F; Alcaraz A
Cancer Genet Cytogenet; 2007 Mar; 173(2):131-5. PubMed ID: 17321328
[TBL] [Abstract][Full Text] [Related]
18. 9p21 index as estimated by dual-color fluorescence in situ hybridization is useful to predict urothelial carcinoma recurrence in bladder washing cytology.
Kawauchi S; Sakai H; Ikemoto K; Eguchi S; Nakao M; Takihara H; Shimabukuro T; Furuya T; Oga A; Matsuyama H; Takahashi M; Sasaki K
Hum Pathol; 2009 Dec; 40(12):1783-9. PubMed ID: 19733894
[TBL] [Abstract][Full Text] [Related]
19. Cytologic diagnosis of low-grade papillary urothelial neoplasms (low malignant potential and low-grade carcinoma) in the context of the 1998 WHO/ISUP classification.
Whisnant RE; Bastacky SI; Ohori NP
Diagn Cytopathol; 2003 Apr; 28(4):186-90. PubMed ID: 12672093
[TBL] [Abstract][Full Text] [Related]
20. Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology.
Daniely M; Rona R; Kaplan T; Olsfanger S; Elboim L; Freiberger A; Lew S; Leibovitch I
Cancer; 2007 Dec; 111(6):517-24. PubMed ID: 17963263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
